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During the past decade, studies of the mechanisms and functional implications of
adult hippocampal neurogenesis (ahNG) have significantly progressed. At present, it
is proposed that adult born neurons may contribute to a variety of hippocampal-
related functions, including specific cognitive aspects and mood regulation. Several
groups focussed on the factors that regulate proliferation and fate determination of
adult neural stem/progenitor cells (NSC/NPC), including clinically relevant drugs. Opiates
were the first drugs shown to negatively impact neurogenesis in the adult mammalian
hippocampus. Since that initial report, a vast array of information has been collected on
the effect of opiate drugs, by either modulating proliferation of stem/progenitor cells or
interfering with differentiation, maturation and survival of adult born neurons. The goal
of this review is to critically revise the present state of knowledge on the effect of opiate
drugs on the different developmental stages of ahNG, as well as the possible underlying
mechanisms. We will also highlight the potential impact of deregulated hippocampal
neurogenesis on patients undergoing chronic opiate treatment. Finally, we will discuss
the differences in the negative impact on ahNG among clinically relevant opiate drugs,
an aspect that may be potentially taken into account to avoid long-term deregulation of
neural plasticity and its associated functions in the clinical practice.
Keywords: opiates, morphine, methadone, tapentadol, neural stem cells, adult neurogenesis, chronic pain,
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ADULT NEUROGENESIS: RELEVANCE IN PHYSIOLOGY,
PATHOLOGY, AND THERAPY
Extensive experimental work demonstrated that new neurons can be generated in adult
mammalian brain (Bergmann et al., 2015). One adult neurogenic area is the dentate gyrus, in the
hippocampal formation. Here, in a subregion called the SubGranular Zone (SGZ), resident neural
stem/progenitor cells (NSC/NPC) are present, can self-renew and give rise to transiently amplifying
progenitor cells which, in turn, generate neuroblasts capable of terminal neuronal differentiation
in the granular cell layer (Kempermann et al., 2003, 2004; Seri et al., 2004; Bonaguidi et al., 2012).
Recently a comprehensive review summarized data on how hippocampal function and related
behavior may be modified by newborn neurons (Gonçalves et al., 2016). At present, adding new
neurons in the hippocampal circuitry is suggested to result in encoding of temporal information
into memories and in cognitive flexibility during new task learning. Pattern separation is the
process that reduces overlap in the representation of similar memories and adult hippocampal
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neurogenesis (ahNG) has been associated with improved
performance in pattern separation behavioral tasks (Aimone
et al., 2009; Sahay et al., 2011). In several studies a reduction
in newborn cells was found to correlate with specific cognitive
deficits, and in particular with spatial memory impairment (Shors
et al., 2001; Aimone et al., 2006; Denis-Donini et al., 2008;
Deng et al., 2010; Couillard-Despres et al., 2011; Aimone et al.,
2014). Context-dependent memory, and specifically performance
in contextual fear conditioning tasks, was also found to be
neurogenesis-dependent (Gonçalves et al., 2016).
A vast array of research investigated factors that regulate
ahNG. External stimuli, including learning, environmental
enrichment, and exercise have profound effects on proliferation/
differentiation of NPC as well as survival of their progeny (van
Praag et al., 2005; Garthe et al., 2016). Aging, chronic stress and
social isolation result in negative impact on ahNG (Schoenfeld
and Gould, 2012; Seib and Martin-Villalba, 2015; Famitafreshi
et al., 2016) and reduction of hippocampal neurogenesis has
been hypothesized to contribute to cognitive decline or mood
alterations associated with those conditions (Aimone et al., 2014).
Extensive research efforts suggest that ahNG may be
deregulated in several neuropsychiatric disorders, including
major depressive disorder (Kempermann and Kronenberg,
2003; Mirescu and Gould, 2006; Denis-Donini et al., 2008;
Kempermann et al., 2008; Yun et al., 2016).
An intringuing aspect of ahNG is its susceptibility to
pharmacological modulation (Duman et al., 2001; Dranovsky
and Hen, 2006; Xu et al., 2006; Zhao et al., 2008; Bortolotto
et al., 2014). Antidepressants increase hippocampal neurogenesis
(Malberg, 2004). Interestingly, such increase requires several
weeks and occurs in parallel with the onset of the antidepressant
effects (Mendez-David et al., 2013). A vast array of experimental
studies demonstrated that antidepressants counteract stress-
reduced ahNG in rodent models of depressive-like disorder
(Pittenger and Duman, 2008; Eisch and Petrik, 2012). An
increased number of hippocampal NPC was reported in
postmortem brain of depressed patients who were treated with
antidepressants (Boldrini et al., 2009, 2012, 2014). Although still
controversial, it has been suggested that antidepressants require
ahNG to exert some behavioral effects in rodents (Santarelli
et al., 2003; David et al., 2009) and that ahNG may contribute
to the antidepressant activity of these drugs in the clinical setting
(Jun et al., 2012). In line with this hypothesis, preclinical studies
evaluating effects on ahNG have become part of the discovery
process of recently approved antidepressant drugs (Soumier et al.,
2009; Guilloux et al., 2013) or of clinically relevant drugs which,
in addition to their approved indications, may potentially exert
antidepressant activity (Valente et al., 2012; Cuccurazzu et al.,
2013).
OPIATES AS NEGATIVE MODULATORS
OF ahNG
Emerging evidence suggest that several psychoactive drugs result
in molecular changes that may negatively affect different aspects
of ahNG (Eisch et al., 2000; Yamaguchi et al., 2004). These
findings have important clinical implications since they raise the
possibility that cognitive dysfunction and/or mood alteration in
the setting of such drug use and/or abuse may, at least in part, be
related to alterations in ahNG (Yun et al., 2016).
Opiate drugs are powerful analgesics which are also among
the most commonly abused addictive drugs. Clinical research
suggested the occurrence of deficits in memory tasks, attention,
verbal fluency and general cognitive performance in opiate
addicts (Cipolli and Galliani, 1987; Guerra et al., 1987; Gruber
et al., 2007). Controversial, but of potential clinical relevance,
is the possibility that cognitive impairment may also occur
in non-addicted patients subjected to chronic opiate treatment
(Sjøgren et al., 2005; Gaertner et al., 2006; Kendall et al.,
2010; Kurita et al., 2011; Højsted et al., 2012). Despite opiate
effects on cognition are difficult to decipher due to their central
depressant effects, preclinical research supports the idea that
chronic administration of opiates may interfere with cognition
independently of performance (Spain and Newsom, 1991; Miladi
Gorji et al., 2008). As an example, in rats, chronic morphine
administration impaired hippocampal dependent long-term
memory retention. Moreover, a selective impairment in spatial
memory, which is considered to be neurogenesis-dependent,
was observed in morphine- compared to vehicle-treated animals
(Miladi Gorji et al., 2008).
Depression often co-occurs with chronic pain and an
emerging line of inquiry is also the association between opiate use
and the risk of depression (Scherrer et al., 2014, 2015, 2016; Smith
et al., 2015). In particular, the onset of a new depressive state has
been associated with longer drug administration (Scherrer et al.,
2016).
Altogether several experimental data suggest that long-term
opiate may produce maladaptive changes in brain structures
involved in cognition and mood regulation such as the
hippocampus. In morphine-dependent animals, mechanisms
responsible for the disruption of long-term memory retention
have been suggested, including effects on dendritic spine stability
(Liao et al., 2005) and long-term potentiation (Nugent et al.,
2007). ahNG is among the forms of neural plasticity which
are regulated by opiates (Zhang et al., 2016a). Actually, opiates
were the first drugs shown to negatively impact hippocampal
neurogenesis (Eisch et al., 2000). Since then, numerous rodent
studies confirmed that finding (Mandyam et al., 2004; Kahn et al.,
2005; Eisch and Harburg, 2006; Arguello et al., 2008; Zhang
et al., 2016b). Based on these reports, it can be hypothesized
that opiates may produce long-lasting effects on the neuronal
circuitry involved in mood and cognition through, at least in part,
disruption of ahNG.
OPIATE EFFECT ON DISTINCT STAGES
AND CELL TYPES OF ahNG
Adult neurogenesis is a complex, multistage process which
consists of a series of developmental events, namely proliferation,
differentiation, migration, maturation and survival of NSC/NPC
and their progeny. Based on their developmental stage, different
cells participating in ahNG can be recognized and classified.
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Briefly, radial-glia-like stem cells, which are both glial fibrillary
acidic protein (GFAP) and nestin positive are defined as
Type-1 cells; Type-2 cells are neural progenitors which are
highly proliferative and nestin+/GFAP−; neuroblasts which
express doublecortin and the polysialylated form of neural cell
adhesion molecule (PSA-NCAM) are referred to as Type-3
cells.
Over the last few years, extensive progress has been made
on how morphine can disrupt neurogenesis in the adult
rodent hippocampus (Zhang et al., 2016a). The first report
correlating opiate administration and adult neurogenesis was by
the group of Amelia Eisch that, in 2000, reported that chronic
morphine, administered via a subcutaneous pellet, decreased
the number of cells which incorporated the thymidine analog
BromodeoxyUridine (BrdU) in rodent SGZ. Importantly, no
effect of acute morphine administration was reported (Eisch et al.,
2000). Since then, extensive evidence has been accumulated on
the negative impact of morphine on NSC/NPC proliferation,
using BrdU or endogenous markers of cell proliferation/cell
cycle (Mandyam et al., 2004; Kahn et al., 2005; Arguello et al.,
2008). Morphine effects appeared to be independent from the
route of administration (subcutaneous pellet vs. intraperitoneal
injection) and to occur during settings of both forced and self-
administration (Mandyam et al., 2004; Kahn et al., 2005; Fischer
et al., 2008).
Survival of newborn cells is also reduced by morphine. After
being born in the dentate gyrus, a large portion of newly
generated cells die within a few days (Dayer et al., 2003).
Chronic morphine treatment decreased granule cell survival
in vivo, by largely reducing the number of 4-week-old BrdU-
labeled cells in the dentate gyrus of drug-treated compared to
control rats (Eisch et al., 2000). Although adult hippocampal
NPC can be isolated and maintained in culture with self
renewal and multipotential properties (Valente et al., 2012;
Cuccurazzu et al., 2013), surprisingly few studies investigated
the effects of opiates in vitro. In one report morphine
exposure in cultured NSC/NPCs resulted not only in reduced
proliferation but also in an increased caspase-3 activity in
nestin+/GFAP+ cells and not in neuroblasts (Willner et al.,
2014).
The detailed mechanisms of regulation of ahNG by morphine
remain to be fully clarified. There is evidence of morphine
acting directly on neural progenitors by engagement of opioid
receptors on their cell surface, but also indirectly. Opiate
analgesics exert their effects through receptor subtypes, referred
to MOR, KOR and DOR, which interact with endogenous opioid
peptides. The contribution of different receptor subtypes to
the negative effects on ahNG has been investigated by both
genetic and pharmacological approaches, pointing to a major role
of MOR. We demonstrated that morphine adversely impacted
on neuronal differentiation, neurite outgrowth and survival
of adult hippocampal NPC and their progeny (Meneghini
et al., 2014). MOR pharmacological blockade confirmed that
the receptor subtype was responsible for morphine effects
(Meneghini et al., 2014). Interestingly, knock-out of MOR
enhanced adult-born granule cell survival in vivo, suggesting
that endogenous opioids may have a negative effect on ahNG
(Harburg et al., 2007). These findings are not consistently
confirmed in vitro. In isolated rat hippocampal NPC, incubation
with β-endorphin increased total DNA content and the number
of cells expressing proliferation markers such as Proliferating
Cell Nuclear Antigen (PCNA) and phosphorylated histone H3
(pHisH3), and these effects were antagonized by naloxone
(Persson et al., 2003a). The same research group reported
that MOR and DOR antagonists decrease proliferation of
cultured NPC (Persson et al., 2003b). Similarly, the long
acting opioid antagonist naltrexone was shown to reduce cell
proliferation in the hippocampus of adult rats (Holmes and
Galea, 2002).
Opiates also interfere with NPC fate specification. Type-3
cell number was diminished by chronic morphine (Kahn et al.,
2005). Moreover, in rat, repeated morphine treatment altered
the GABAergic phenotype of adult-born hippocampal granule
cells by increasing the GABA synthesizing enzyme glutamate
decarboxylase-67 (Kahn et al., 2005). A more detailed analysis
using BrdU and Ki67 proliferation markers concluded that
morphine treatment increased Type-2b and decreased Type-
3 cells in mouse SGZ (Arguello et al., 2008). Also in vitro
a remarkable decrease in neuronal differentiation of mouse
hippocampal NPC by morphine has been demonstrated, an
effect which is MOR mediated (Meneghini et al., 2014;
Willner et al., 2014). Chronic treatment with MOR and
DOR antagonists decreased adult NSC/NPC differentiation
into astrocytes and oligodendrocytes, while favoring their
neuronal differentiation. In the same experimental setting KOR
antagonists had no effect (Persson et al., 2003b). It cannot be
excluded that opiates may also affect astrocytes (that express
opioid receptors) which, in turn, can modulate ahNG with
different mechanisms, including via secreted molecules (Cvijetic
et al., 2017). Immature adult generated neurons are excited
by GABA (Ge et al., 2006) and they need excitatory signals
from the preexisting circuit to complete their differentiation
and maturation. Opiate agonists may interfere with this process
by decreasing GABA release (Neumaier et al., 1988). Studies
are needed to further understand the role of endogenous
opioids and receptors in ahNG homeostasis (Lutz and Kieffer,
2013).
The intracellular signaling pathways involved in the negative
effects of morphine on neural progenitors were investigated
only in a few studies. The basic helix-loop-helix transcription
factor NeuroD1 is negatively regulated by morphine in
NPC cultures (Zheng et al., 2010). Under the conditioned
place preference paradigm morphine, through a mechanism
involving NeuroD1, impaired the differentiation of NSC/NPC
into immature neurons (Zhang et al., 2016b). Xu et al.
(2015) demonstrated that, in presence of morphine, mouse
NPC preferentially differentiated into astrocytes and not
neurons. This effect was mediated by MOR and by miR-
181a/Prox1/Notch1 pathway activation. Interestingly, the same
group also demonstrated that miR-181a/Prox1/Notch1 pathway
regulates NPC differentiation in a ligand-dependent manner (Xu
et al., 2015), pointing to differences in the effect of distinct opiate
molecules on mouse NPC differentiation. Morphine modulates
the lineage-specific differentiation of NPC by PKCε-dependent
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ERK activation with subsequent TAR RNA-binding protein
(TRBP, a cofactor of Dicer) phosphorylation and miR-181a
maturation. Conversely fentanyl activated ERK via the β-arrestin-
dependent pathway, followed by nuclear translocation of
phosphoERK.
Overall, available data support the idea that morphine
negatively affects neurogenesis acting on multiple cellular types
and stages of the neuroplasticity process. Morphine properties on
neurogenesis are also shared by other opiates. The partial agonist
buprenorphine, when administered via subcutaneous injections
over a 3-day period, reduced the number of actively proliferating
cells in the hippocampus of adult mice (Pettit et al., 2012). On
the other hand, differences in the signaling pathways activated in
NPC by different opiate drugs may underlie potential differences
in their impact on ahNG.
In the future studies, should be specifically designed to
correlate more stringently the disruptive cognitive effects of
distinct opiates with specific alterations in ahNG and to
discriminate those that are strictly dependent on neurogenesis
from the ones that are neurogenesis-independent.
NOT ALL OPIATES ARE CREATED
EQUAL: DIFFERENT IMPACT ON
HIPPOCAMPAL NEUROGENESIS OF
DISTINCT DRUGS
A recent in vivo study in rat found that chronically administered
methadone does not alter parameters relevant to ahNG
including the number of Ki67-, doublecortin-, or BrdU-
immunoreactive cells (Sankararaman et al., 2012). These results
suggest that, unlike morphine, methadone may not alter
hippocampal plasticity. Interestingly methadone is an atypical
opiate, since it is a MOR agonist and a non-competitive
NMDA antagonist (Gorman et al., 1997). Incidentally, NMDA
antagonists positively modulate hippocampal neurogenesis in
rodents (Nacher et al., 2001; Maekawa et al., 2009). Future
investigation should address whether the lack of negative effects
on ahNG by methadone could be ascribed to its NMDA receptor
antagonism.
Tapentadol is a centrally acting analgesic drug which
combines, in a single molecule, MOR agonism and blockade
of norepinephrine (NE) reuptake (Tzschentke et al., 2007).
Since ahNG is positively modulated by NE (Jha et al.,
2006; Kulkarni and Dhir, 2007), we compared the effects
of morphine and tapentadol on differentiation, maturation
and survival of neurons generated from adult hippocampal
NPC in vitro. Morphine significantly hampered neuronal
differentiation, neurite outgrowth and survival of adult NPC
and their progeny (Meneghini et al., 2014). In presence of
tapentadol cell survival was not affected. Conversely, tapentadol
reduced the number of newly generated neurons and their neurite
outgrowth but only at concentrations which activate MOR
and not at higher ones which block NE reuptake. Specifically,
tapentadol proneurogenic and antiapoptotic effects appeared to
be mediated by activation of β2 and α2 adrenergic receptors,
respectively (Meneghini et al., 2014). As a proof of concept,
in the same experimental model, morphine antineurogenic
and proapoptotic effects were counteracted by reboxetine, an
antidepressant which selectively blocks noradrenaline reuptake
(Meneghini et al., 2014). In line with these in vitro results,
chronic administration of a clinically relevant dose of tapentadol
did not negatively affect proliferation and differentiation
toward the neuronal lineage of newly generated cells in adult
mouse hippocampus (Meneghini et al., 2014). Altogether these
data support the idea that the noradrenergic component in
tapentadol has the potential to counteract the adverse MOR-
mediated effects on hippocampal neurogenesis both in vitro
and in vivo. In principle, this counter-balancing effect may
result, like for the atypical opiate methadone, in less or
no dysfunction in adult neurogenesis and, potentially, in
neurogenesis-associated functions after long-term treatment
in vivo.
CLINICAL IMPLICATIONS AND
LONG-TERM PERSPECTIVES
Cognitive dysfunction has been often reported in opiate drug
abusers (Eisch and Harburg, 2006; Canales, 2007). Moreover,
major depression represents an important comorbidity in
chronic pain states and recent work has suggested an association
between prolonged opiate use and the risk of new onset
depression (Scherrer et al., 2015, 2016).
Preclinical evidence summarized in this review support the
idea that disruption of ahNG may, at least in part, contribute
to the long-lasting effects produced by some opiates, like
morphine, on cognition and mood regulation. Although
preliminary, these preclinical data mark the importance of
taking into account inhibition of ahNG as a potential long-
term consequence of opiate use also in the clinical setting.
This aspect appears even more relevant in consideration
of the fact that chronic pain per se may induce profound
changes in hippocampal plasticity, including deregulated
hippocampal neurogenesis (Mutso et al., 2012; Dellarole et al.,
2014).
While we wait for a definitive answer on any causal correlation
between long term-opiate treatment and cognitive and emotional
impairment in chronic pain patients, preclinical studies should
be undertaken to increase our current understanding of the
cellular and molecular effects of opiates on adult NPC and
their progeny. Moreover, experimental work should be aimed
at understanding differences between distinct opiates in their
potential for disrupting ahNG. Ultimately these studies may
help us to unravel different level of risk associated with distinct
treatment options. In principle, drugs like methadone and
tapentadol may result, after drug long-term treatment, in reduced
or absent dysfunction in ahNG compared to morphine and
other opiates. Alternatively, other analgesic drugs which do
not reduce but rather increase ahNG in preclinical models
like pregabalin/gabapentin (Valente et al., 2012) and acetyl-L-
carnitine (Cuccurazzu et al., 2013) could be proposed, at least in
neuropathic pain where they are effective. A better understanding
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of whether different opiate molecules affect molecular and
cellular aspects of ahNG may also help designing and developing
novel analgesic drugs for chronic pain states. Several drugs
acting at different targets are under development for chronic
pain treatment (Sasikumar et al., 2010; Bennett et al., 2012;
Chang et al., 2015; Yaksh et al., 2015). We propose that future
drug design should take into consideration the development of
powerful analgesics that, by preserving ahNG, may also protect
cognitive functions and counteract mood alterations which often
represent comorbidities in chronic pain states.
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